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G R A P H I C A L A B S T R A C T
A B S T R A C T
Anticoagulant rodenticide (AR) products are used globally to control rodent pests in domestic, urban, agricultural
and industrial environments. However, there is a substantial volume of evidence that non-target vertebrate
wildlife i.e. predators and scavengers in particular and other animals, are vulnerable to contamination via direct
or indirect routes of exposure. The determination of multiple AR residues in liver tissue samples that can range
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rom remnants of a small bird of prey liver to an intact liver from a large mammal is complicated as residue levels
ncountered can vary considerably too. So, the utilisation of ultra-sensitive systems has to be carefully considered
n order to allow routine application of the method to all sample compositions presented for analysis. The UHPLC–
SMS method described now:
permits quantitative analysis of ultra-low levels of multiple-residues (0.0025–1 mg kg1) in a single experiment.
uses the same U(H)PLC column for the determination of AR and multiple-pesticide residue in similar
specimens.
allows higher sample throughput due to shaking rather than tumbling of samples during the extraction
procedure.
rown Copyright © 2018 Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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ethod details
eagents and preparation of solvent standards
All AR standards were certified reference materials (purity ranging from 98% to 99.5%) and
urchased from Dr. Ehrenstorfer (Augsburg, Germany). Solvents used throughout were HPLC-grade
nless specified otherwise and supplied by Rathburn Chemicals Ltd. (Walkerburn, Scotland UK). Stock
olutions (400 mg ml1) of 8 individual pesticides were prepared using HPLC-grade methanol.
liquots were taken to compose a standards mixture (5 mg ml1) of brodifacoum, bromadiolone,
hlorophacinone, coumatetralyl, difenacoum, diphacinone, flocoumafen and warfarin (standard A).
rom this and a 10 mg ml1 standard of difethialone (pre-purchased in methanol – standard B), an
ntermediate solution at 0.4 mg ml1 was prepared by combining 1.6 ml of standard A and 0.8 ml of
tandard B to a final volume of 20 ml with methanol (solvent standard 8). This intermediate solution
as then used to prepare a series of solvent standards (1–7) as detailed below in Table 1.
reparation of chicken liver (blank) matrix
50 g portions of ‘chopped’ chicken liver (intended for human consumption and purchased from
ocal retail outlets) were weighed separately into 4  1 l beakers. 0.5 g ( 0.01 g) of solid ascorbic acid
as added to each beaker and the contents were mixed thoroughly using a glass rod. 500 g of
nhydrous sodium sulphate was then added to each beaker and mixed thoroughly in order to absorb
oisture.
The contents were allowed to dry for 30 min and mixed again until a friable mixture was obtained.
he contents of each beaker was divided equally into 250 ml bottles and 100 ml ( 10 ml) of extraction
olvent (1:1 v/v chloroform:acetone plus 0.075% ascorbic acid) was added. The bottles were securely
apped and placed on a shaker for at least an hour at 135 strokes per minute. The filtrate and washings
rom each extraction bottle were collected into 250 ml round-bottomed flasks after being passed
hrough a qualitative filter paper (18.5 cm).
The contents of each 250 ml round bottomed flask were combined and evaporated to dryness using
 rotary evaporator with heated bath (IKA, Oxon UK). The bath temperature should not exceed 40 C.
pproximately 20 ml cyclohexane:ethylacetate (1:1 v/v) was used to re-dissolve the residual material
ith the aid of ultrasonication and transferred to a volumetric flask (100 ml). The final extract was
ade up to volume with cyclohexane:ethylacetate (1:1 v/v) to give a final matrix concentration of
 g ml1. The extract is now ready for clean-up using Gel Permeation Chromatography (GPC).
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GPC clean-up
Twenty x 4 ml portions of crude chicken liver extract were filtered into GPC vials which were then
sealed and placed into the GPC sample rack. The crude extracts (2 ml) were applied to the GPC
column and automated GPC clean-up was performed using a Gilson GX-271 Liquid Handler system
(Gilson U.K., Luton, UK) and LC Tech column-082 500  40 mm, 25 mm, bed length 320 mm, 50 g: (ARC
Sciences, Alton UK) in ethylacetate/cyclohexane and the method (Table 2) yielded an elution profile
shown in Table 3 below. The solvent mixture employed was cyclohexane:ethylacetate (1:1 v/v)
The cleaned-up extracts were combined and evaporated just to dryness by rotary evaporation (bath
temperature should not exceed 40 C). The residue was redissolved with the aid of ultrasonication in
5 mM methanolic ammonium acetate solution (5 ml) and quantitatively transferred to a volumetric
flask (20 ml). This gave a final matrix concentration of 4 g ml1.
A separate experiment was and is conducted to check the validity of the ‘rodenticide-free’ chicken
liver before it was/is used to prepare matrix-matched standards and spikes.
Preparation of matrix-matched standards
Matrix-matched standards were prepared as follows: Each solvent standard (1–8: Table 1) was
diluted 2-fold into 5 ml volumetric flask that contained 0.25 ml of chicken liver matrix solution. They
were made up to volume using 5 mM methanolic ammonium acetate solution in order to produce the
following range of matrix-matched standards: 0.0005 mg ml1, 0.001 mg ml1, 0.002 mg ml1,
Table 1
Preparation of ‘pure’ solvent standards.




Solvent std 8 in
methanol
1.6 ml Rod Mix (5 mg ml1) and 0.8 ml
difethialone (10 mg ml1)
0.4 20 ml
Solvent std 7a 5.0 ml solvent std 8 0.2 10 ml
Solvent std 6a 2.5 ml solvent std 8 0.1 10 ml
Solvent std 5a 2.0 ml solvent std 8 0.04 20 ml
Solvent std 4a 5.0 ml solvent std 5 0.02 10 ml
Solvent std 3a 1.0 ml solvent std 5 0.004 10 ml
Solvent std 2a 0.5 ml solvent std 5 0.002 10 ml
Solvent std 1a 0.5 ml solvent std 4 0.001 10 ml
a All made up to volume using 5 mM methanolic ammonium acetate solution.
Table 2
GPC clean-up method.
Refill Speed 125 ms
Compressibility 46 M bar 1
Head size 10
Calibration Mode
Flow rate 5.0 + 0.1 ml min1
Injection volume 3000 ml
Number of fractions 35
Collection time 1 min
Sample Mode
Flow rate 5.0 + 0.1 ml min1
Injection volume 3000 ml
Number of fractions 1
Collection time 21 min






























.01 mg ml1, 0.02 mg ml1, 0.05 mg ml1, 0.1 mg ml1 and 0.2 mg ml1 (final matrix concentration R
.2 g ml1)). Both, the matrix-matched and the solvent standards were prepared every 7 days to
nsure the correct quantification of samples.
ample preparation and clean-up
Liver tissue was finely chopped and a portion ( 4 g) was weighed into a beaker (100 ml) then
0  1 mg of solid ascorbic acid was added and mixed thoroughly using a glass rod. Sufficient amount
f anhydrous sodium sulphate was added to absorb moisture. The mixture was left to dry for 20–
0 min until friable then transferred into an extraction bottle (250 ml) and 100  10 ml of extraction
olvent was added. The bottle was securely capped and placed on a shaker for at least an hour at
35 strokes per minute. The crude extract was filtered off through a qualitative filter paper (18.5 cm)
ith washings into a round bottom flask (150 ml) and evaporated just to dryness by rotary evaporation
bath temperature not exceeding 40 C). The dry residue was re-dissolved in approximately 2 ml of
yclohexane/ethyl acetate (1:1 v/v) and the resulting extract was transferred quantitatively to a
olumetric flask (4 ml) and made up to volume with the same solvent mixture.
Liver tissue extracts were filtered through glass fibre syringe filters (25 mm, 1.2 mm) and 2 ml
pplied to the GPC column (approx. 2 g of extract). The first 60 ml of eluate were discarded and the
ext 100 ml collected. The cleaned-up extract was evaporated just to dryness using a rotary evaporator
bath temperature not exceeding 40 C) and re-dissolved, with the aid of ultrasonication in 5 mM
ethanolic ammonium acetate solution (10 ml) for analysis by UHPLC–MSMS. It is not unusual for the
vailable sample weight to be <<<4 g. Therefore it is often necessary to adjust the final volume of
 mM methanolic ammonium acetate used in order to maintain a matrix concentration of 0.2 g ml1.
reparation of fortified liver matrix AQC samples (spikes)
Blank liver tissue samples were fortified, prior to extraction, to generate 6 liver spikes at
.005 mg kg1, 6 liver spikes at 0.02 mg kg1 and 6 liver spikes at 0.1 mg kg1. Three spike solutions
ere prepared as follows:
 Spike solution 1: 0.4 mgml1: 1.6 ml of standard A (5 mg ml1) and 0.8 ml of standard B (10 mg ml1)
into 20 ml volumetric flask
 Spike solution 2: 0.08 mg ml1: 4 ml of Spike solution 1 into 20 ml volumetric flask
 Spike solution 3: 0.02 mgml1: 1 ml of Spike solution 1 into 20 ml volumetric flask
Then, 1 ml of spike solution 3 0.02 mg ml1 was added to 6 blank liver samples (4 g) to generate
pikes at 0.005 mg kg1. 1 ml of spike solution 2 0.08 mg ml1 and 1 ml of spike solution 1 0.4 mg ml1
ere used to generate spike samples at 0.02 mg kg1 and 0.1 mg kg1 respectively. All spiked samples
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UHPLC–MSMS
UHPLC–MSMS was achieved using a Nexera X2 UHPLC system coupled to a LCMS-8050 triple
quadrupole mass spectrometer (Shimadzu Corporation, Japan). The chromatographic separation was
performed using a Kinetex C18 50  4.6 mm, 2.6 mm analytical column (Phenomenex, Macclesfield,
UK) maintained at 40 C. Mobile phases were (A) water/methanol 95/5 v/v, 5 mM ammonium acetate,
and (B) methanol, 5 mM ammonium acetate. The flow was set at 0.4 ml min1 and the volume injected
was 3 ml. The total run time was 6 min and the gradient was programmed as follows: 0 min, 10% B;
0.3 min, 40% B; 3.1 min, 98% B; 4.1 min, 98% B; 4.2 to 6.00 min, equilibration time. Retention times of
each compound were initially determined in the MRM data acquisition and negative ionisation mode
following assignment of the corresponding molecular anion species.
Analyses were performed using electrospray ionisation (ESI) in negative ionisation mode using a
Dual Ionisation Source (DUIS). A pause time of 2 ms and dwell time 5–10 ms were used. Argon of 99.9%
purity (BOC Manchester, UK) was used as collision gas (270 kPa cell pressure). A combined air and
nitrogen generator (Peak Scientific, Renfrew, UK) was used to supply nitrogen as the drying and
nebulizing gas, and air as the heating gas, set at universally applied values of 10 l min1, 2 l min1 and
10 l min1, respectively. The interface temperature was 300 C, the DL (Desolvation Line Assembly)
temperature held at 250 C and heating block temperature was 400 C. The DUIS interface and corona
needle voltages (ESI negative mode) were maintained at 3.00 kV and 3.50 kV, respectively. The
UPHLC–MSMS system was controlled and the data acquired and processed using ‘Labsolutions’
software. Data were processed using ‘Labsolutions Insight’ software (Shimadzu Corporation, Japan).
The optimum multiple reaction monitoring (MRM) transitions were determined for each analyte
by flow-injection analysis of methanolic solutions of the individual solvent standard directly into the
ionisation source. Optimum collision energy values were determined for each analyte/MRM
transition. The precursor ion ! product ion (MRM) transitions listed in Table 4 were used for
construction of the associated calibration curves and subsequent quantitative screening and
confirmation of residues in quality control samples and real samples.
Validation and analytical quality control
In order to assess the dynamic range of quantitation of each AR in this UHPLC–MSMS system, we
investigated (i) the linearity of calibration over the range of residue concentrations, (ii) accuracy and
limitations of quantitation using quadratic calibration and (iii) opportunity to eliminate sample
dilution and repeat analyses.
This was achieved following the use of multiple AR/MRM transitions i.e. of varying relative
intensity, to generate corresponding calibration curves. At least 3 MRMs per AR were identified and
processed (Fig. 1). Each AR/MRM combination selected yielded quadratic calibration curves over a
residue concentration range covering 3-orders of magnitude (0.0005–0.5 mgml1) and this was
generally irrespective of the relative intensity of the selected MRM.
However, quantitation of some AR standards at levels close to the lowest calibration level (LCL) was
not reliable using the above range of calibration standards and quadratic calibration. Consequently, it was
practical and appropriate to routinely generate restricted ‘low-level’ 5-point linear calibration curves i.e.
0.025–0.1 mg kg1 since thiscovered the range of ARresiduesmost commonly detected and encountered
[1,2]. However, data from the extended (8-point) range of calibration standards was also collected.
Calibration was acceptable if the correlation coefficient (R2) values 	0.96 i.e. for either fit [3].
The procedure was subsequently validated following a series of experiments whereby a minimum
of 5 replicate spikes at three different levels were analysed to generate mean recovery values and to set
a limit of quantitation (LoQ). The LoQ was set when a signal to noise ratio of 	3:1 (peak to peak) was
achieved for the lowest calibration level. The two most intense MRM transitions (screen and
confirmation – Table 4) were monitored for each AR. Recovery values were deemed acceptable if they
fell within the range 60%–140%, yielded a mean value between 70%–90% and a corresponding
co-efficient of variation (CV%) 20%. Retention Time tolerance was set at  0.1 min and the ion ratio
limit was  30% difference i.e. in accordance with SANTE AQC and validation guidelines for multiple
pesticide residues analysis in food and feed [3]. Table 5 contains validation data obtained for 7 out of













 ARs as recoveries for chlorophacinone and diphacinone were erratic and the method therefore
eemed qualitative for these two ARs. The LoQ was determined and set at 0.003 mg kg1 (R
.0005 mg ml1) for 7/9 ARs. The uncertainty of measurement for the liver tissue validation data i.e.
xpanded uncertainty = 21% [4]. This was determined from validation experiments conducted on
ifferent days and by different analysts. The dataset used to determine and refresh the expanded
ncertainty values is augmented by incorporation of AQC data from successive and longer term
xperimental batches.
able 4
R structures, formulae, precursor ! product ion (MRM) transitions and ionisation parameters (Electrospray: negative
on mode).
AR M Ion MRM
screen
CE MRM confirmation CE RT
Warfarin 308 [MH] 307.1 > 250.05 23 307.1 >161.10 20 2.75
Coumatetralyl 292 [MH] 291.3 > 141.15 27 291.3 > 247.10 23 2.79
Diphacinone 340 [MH] 339.1 >167.15 24 339.1 >116.10 45 3.15
Chlorophacinone 374 [MH] 373.1 > 201.10 23 373.1 >145.05 23 3.48
Bromadiolone 526 [MH] 525.2 > 250.10 37 525.2 > 181.15 36 3.72
Difenacoum 444 [MH] 443.3 > 293.15 34 443.3 > 135.25 36 3.86
Flocoumafen 542 [MH] 541.3 > 382.15 26 541.3 > 161.05 35 3.98
Brodifacoum 522 [MH] 521.2 > 135.10 38 521.2 > 143.10 53 4.10
Difethialone 538 [MH] 537.2 > 151.10 38 537.2 > 371.00 36 4.13
 = Nominal Mass; CE = Collision Energy (v): RT = Retention Time (mins).
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Residue levels in real sample extracts were interpolated from calibration data generated in the
same experimental batch (i.e. standards, matrix/reagent blanks, AQC sample and real samples).
Whenever higher level residues were indicated i.e. >>0.1 mg kg1, the higher level standards were
‘retrospectively’ included and a quadratic 8-point calibration curve (0.025–1 mg kg1) was generated
and used for quantitation. The utility of this approach was proven by comparison of results obtained
following analysis of diluted and original sample extracts that contained high-level residues, using
linear and quadratic calibration, respectively, Table 6.
The extended calibration range was reduced for routine use to 0.0005–0.2 mg ml1. Exclusion of the
0.5 mg ml1 standard eliminated risk of carry-over and reduced consumption of expensive reference
materials without any adverse effect on quantitation of gross residues. Consequently, dilution may still
be required but more infrequently.
Additional information
The environmental impact of legitimate AR use is monitored in many countries as data collected
underpins ongoing review, risk-assessment and refinement of the conditions and guidance for use [5].
Monitoring activities can also confirm or refute the mis-use of AR i.e. suspected accidental, negligent or
deliberate poisonings of non-target vertebrate wildlife, pets and livestock. In the United Kingdom,
surveillance of the impact of rodenticide use is facilitated by the UK’s Wildlife Incident Investigation
Scheme (WIIS) which is operated in Scotland by Science and Advice for Scottish Agriculture (SASA) on
behalf of the Scottish Government [6]. The active ingredients present in AR products currently approved
Fig. 1. AR/MRM ion chromatograms yielded by 0.001 mgml1 matrix-matched standard. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)





or use in the UK include; brodifacoum, bromadiolone, coumatetralyl, difenacoum, difethiolone,
ocoumafen and warfarin. Chloropacinone and diphacinone are still sought as legacy chemicals and to
eveal any illegal use.
Table 5
Method Performance Characteristics: Recoveries and CVs in fortified liver tissue.
Fortification Level mgkg1
AR 0.1 (n = 6) 0.02 (n = 6) 0.005 (n = 5)
Mean CV% Mean CV% Mean CV%
Warfarin screen 106 6 105 4 100 7
Warfarin conf 106 6 105 5 99 6
Coumatetralyl screen 105 5 107 4 100 3
Coumatetralyl conf 107 5 106 5 104 3
Bromadiolone screen 88 3 85 9 76 8
Bromadiolone conf 89 5 83 6 77 18
Difenacoum screen 91 3 86 7 77 9
Difenacoum conf 91 3 87 8 77 9
Flocoumafen screen 85 3 86 8 80 10
Flocoumafen conf 86 3 86 11 76 13
Brodifacoum screen 83 4 78 12 77 17
Brodifacoum conf 83 7 83 12 76 12
Difethialone screen 79 3 80 5 82 15
Difethialone conf 85 3 84 11 87 6
Table 6
Comparison of quantitation results of high level bromadiolone residues in diluted and original sample
extracts using linear and quadratic calibration, respectively.
Matrix Linear Std. Range (0.0005–0.01 mgml1): DILUTED
AR Bromadiolone 1 Bromadiolone 2
MRM 525.2 > 250.10 525.2 > 181.15
R2 0.9999 0.9999
Sample mg ml1 mg kg1 mg ml1 mg kg1
Fox/1 100 ml/2 g 0.0069 0.3450 0.0073 0.3650
Fox/2 100 ml/1.35 g 0.0077 0.5704 0.0077 0.5704
Fox/3 200 ml/2 g 0.0080 0.8000 0.0079 0.7900
Dog/1 500 ml/2 g 0.0064 1.6000 0.0062 1.5500
Matrix Quadratic Std. Range (0.0005–0.5 mgml1): ORIGINAL
R2 0.9997 0.9996
Sample mg ml1 mg kg1 mg ml1 mg kg1
Fox/1 10 ml/2 g 0.0743 0.3715 0.0736 0.3680
Fox/2 5 ml/1.35 g 0.1474 0.5459 0.1452 0.5378
Fox/3 10 ml/2 g 0.1707 0.8535 0.1665 0.8325
Dog/1 10 ml/2 g 0.3744 1.8720 0.3677 1.8385
Measured concentrations in real samples are not corrected for recovery.
Initial gross residue determinations included a top calibration standard of 0.5 mgml1.
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Fig. 2. (a) Brodifacoum, bromadiolone and difenacoum residues detected in a red kite (Milvus milvus). Screen and confirmation
MRMs from liver extract, proximate standards and ion ratio compliance. Fig. 2b, shows data that confirmed (suspected)
poisoning of numerous domestic chickens accidentally and fatally exposed to difethialone AR product used at a farm by the
owner. (b) Confirmation of accidental difethialone poisoning of domestic chickens (Gallus gallus domesticus): Screen,
confirmation and proximate standard MRMs *Actual Residue = 0.45 mgkg1 (1:20) dilution required. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)




















All samples used for validation studies and subsequent routine deployment of the method were
ubmitted as part of WIIS-Scotland surveillance program. The method is also routinely applied, but not
currently) validated, for the determination of multiple-AR residues in a variety of matrices i.e.
uspected bait samples, plasma, whole-blood, viscera and unknown substances, contaminated
aterials/items and formulated products. Fig. 2a and b show typical results obtained following
outine application of the method which has significantly improved experimental precision and
orkflow efficiency. Fig. 2a presents experimental data confirming the presence of bromadiolone,
rodifacoum and difenacoum residues in the liver of a red kite, which is a protected species in the UK.
xposure was concluded to be due to consumption of dead or dying rodents.
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